Clinical Trial Update: Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating axillary reverse mapping to prevent lymphedema in breast cancer patients undergoing axillary lymph node dissection; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer Stage I, Breast Cancer Stage II | Phase 3 | Status: ACTIVE_NOT_RECRUITING